表紙
市場調査レポート

世界の眼科関連の提携条件・契約

Global Ophthalmics Partnering 2010-2016: Deal trends, players and financials

発行 Current Partnering, a division of Wildwood Ventures Limited 商品コード 258786
出版日 ページ情報 英文 500+ Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=101.51円で換算しております。
Back to Top
世界の眼科関連の提携条件・契約 Global Ophthalmics Partnering 2010-2016: Deal trends, players and financials
出版日: 2016年02月01日 ページ情報: 英文 500+ Pages
概要

当レポートでは、世界の眼科市場における企業提携の締結動向とその内容(提携条件)について分析し、近年の企業提携/取引形成状況とその特徴(種類別・開発段階別・適応症別)、平均的な取引条件、代表的な資本取引の概略、大手医薬品企業の動向、近年の提携取引一覧とその内訳といった情報を盛り込んでいます。

エグゼクティブ・サマリー

第1章 イントロダクション

第2章 眼科関連の取引形成の動向

  • イントロダクション
  • 過去数年間の眼科関連の提携動向
  • 大手医薬品企業の眼科関連の取引形成活動
  • 眼科関連の提携:取引の種類別
  • 眼科関連の提携:開発段階別
  • 眼科関連の提携:適応症別
  • 眼科関連の提携の平均的な取引条件
    • 取引総額 (headline values)
    • 前払い金
    • マイルストーン払い
    • ロイヤルティ率

第3章 代表的な眼科関連の資本取引

  • イントロダクション
  • 代表的な資本取引:金額別

第4章 大手医薬品企業の眼科関連の資本取引

  • イントロダクション
  • 大手医薬品企業との提携取引の活用方法
  • 大手医薬品企業各社のプロファイル

第4章 大手バイオテクノロジー企業の眼科関連の資本取引

  • イントロダクション
  • 大手バイオテクノロジー企業との提携取引の活用方法
  • 大手バイオテクノロジー企業各社のプロファイル

第6章 眼科関連の提携契約の一覧

  • イントロダクション
  • 関連企業一覧
  • 取引の種類別
  • 開発段階別
  • 技術の種類別

第7章 治療標的別の取引形成

  • イントロダクション
  • 治療標的別の資本取引

付録

  • 付録1 眼科関連の資本取引の一覧:企業名別(A〜Z)、通算7年間分
  • 付録2 眼科関連の資本取引の一覧:取引の種類別、通算7年間分
  • 付録3 眼科関連の資本取引の一覧:開発段階別、通算7年間分
  • 付録4 眼科関連の資本取引の一覧:技術の種類別、通算7年間分
  • 付録5 提携リソースセンター
    • オンライン提携
    • 提携関連イベント
    • 関連調査
    • 取引の種類の定義

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: CP2219

The Global Ophthalmics Partnering 2010-2016: Deal trends, players and financials report provides comprehensive understanding and unprecedented access to the ophthalmics partnering deals and agreements entered into by the worlds leading healthcare companies

Global Ophthalmics Partnering 2010 to 2016 provides the full collection of Ophthalmics disease deals signed between the world's pharmaceutical and biotechnology companies since 2010.

  • Trends in Ophthalmics partnering deals
  • Financial deal terms for headline, upfront and royalty by stage of development
  • Ophthalmics partnering agreement structure
  • Ophthalmics partnering contract documents
  • Top Ophthalmics deals by value
  • Most active Ophthalmics dealmakers

Most of the deals included within the report occur when a licensee obtains a right or an option right to license a licensor's product or technology. More often these days these deals tend to be multi-component including both a collaborative R&D and a commercialization of outcomes element.

The report takes readers through the comprehensive Ophthalmics disease deal trends, key players and top deal values allowing the understanding of how, why and under what terms companies are currently entering Ophthalmics deals.

The report presents financial deal terms values for Ophthalmics deals, where available listing by overall headline values, upfront payments, milestones and royalties enabling readers to analyse and benchmark the value of current deals.

The initial chapters of this report provide an orientation of Ophthalmics dealmaking trends.

Chapter 1 provides an introduction to the report.

Chapter 2 provides an overview of the trends in Ophthalmics dealmaking since 2010 covering trends by year, deal type, stage of development, technology type and therapeutic indication.

Chapter 3 includes an analysis of financial deal terms covering headline value, upfront payment, milestone payments and royalty rates.

Chapter 4 provides a review of the leading Ophthalmics deals since 2010. Deals are listed by headline value. The chapter includes the top 25 most active Ophthalmics dealmakers, together with a full listing of deals to which they are a party. Where the deal has an agreement contract published at the SEC a link provides online access to the contract.

Chapter 5 provides comprehensive access to Ophthalmics deals since 2010 where a deal contract is available, providing the user with direct access to contracts as filed with the SEC regulatory authorities. Each deal title links via Weblink to an online version of the deal record contract document, providing easy access to each contract document on demand.

Chapter 6 provides a comprehensive directory of all Ophthalmics partnering deals by specific Ophthalmics target announced since 2010. The chapter is organized by specific Ophthalmics therapeutic target. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

In addition, a comprehensive appendix is provided with each report of all Ophthalmics partnering deals signed and announced since 2010. The appendices are organized by company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc) and technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

The report also includes numerous tables and figures that illustrate the trends and activities in Ophthalmics partnering and dealmaking since 2010.

In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of Ophthalmics technologies and products.

Report scope

Global Ophthalmics Partnering 2010 to 2016 is intended to provide the reader with an in-depth understanding and access to Ophthalmics trends and structure of deals entered into by leading companies worldwide.

Global Ophthalmics Partnering 2010 to 2016 includes:

  • Trends in Ophthalmics dealmaking in the biopharma industry since 2010
  • Analysis of Ophthalmics deal structure
  • Access to headline, upfront, milestone and royalty data
  • Access to hundreds of Ophthalmics deal contract documents
  • Comprehensive access to over 3500 Ophthalmics deal records
  • The leading Ophthalmics deals by value since 2010
  • Most active Ophthalmics dealmakers since 2010

In Global Ophthalmics Partnering 2010 to 2016, available deals and contracts are listed by:

  • Headline value
  • Upfront payment value
  • Royalty rate value
  • Stage of development at signing
  • Deal component type
  • Technology type
  • Specific therapy indication

Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

The Global Ophthalmics Partnering 2010-2016 report provides comprehensive access to available deals and contract documents for over 400 ophthalmics deals. Analyzing actual contract agreements allows assessment of the following:

  • What are the precise rights granted or optioned?
  • What is actually granted by the agreement to the partner company?
  • What exclusivity is granted?
  • What is the payment structure for the deal?
  • How are the sales and payments audited?
  • What is the deal term?
  • How are the key terms of the agreement defined?
  • How are IPRs handled and owned?
  • Who is responsible for commercialization?
  • Who is responsible for development, supply, and manufacture?
  • How is confidentiality and publication managed?
  • How are disputes to be resolved?
  • Under what conditions can the deal be terminated?
  • What happens when there is a change of ownership?
  • What sublicensing and subcontracting provisions have been agreed?
  • Which boilerplate clauses does the company insist upon?
  • Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?
  • Which jurisdiction does the company insist upon for agreement law?

Benefits

Global Ophthalmics Partnering 2010 to 2016 provides the reader with the following key benefits:

  • In-depth understanding of Ophthalmics deal trends since 2010
  • Access Ophthalmics deal headline, upfront, milestone and royalty data
  • Research hundreds of actual contracts between Ophthalmics partner companies
  • Comprehensive access to over 750 links to actual Ophthalmics deals entered into by the world's biopharma companies
  • Indepth review of Ophthalmics deals entered into by the top 25 most active dealmakers
  • Benchmark the key deal terms companies have agreed in previous deals
  • Identify key terms under which companies partner Ophthalmics opportunities
  • Uncover companies actively partnering Ophthalmics opportunities

Table of Contents

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in Ophthalmics dealmaking

  • 2.1. Introduction
  • 2.2. Ophthalmics partnering over the years
  • 2.3. Ophthalmics partnering by deal type
  • 2.4. Ophthalmics partnering by industry sector
  • 2.5. Ophthalmics partnering by stage of development
  • 2.6. Ophthalmics partnering by technology type
  • 2.7. Ophthalmics partnering by therapeutic indication

Chapter 3 -Financial deal terms for Ophthalmics partnering

  • 3.1. Introduction
  • 3.2. Disclosed financials terms for Ophthalmics partnering
  • 3.3. Ophthalmics partnering headline values
  • 3.4. Ophthalmics deal upfront payments
  • 3.5. Ophthalmics deal milestone payments
  • 3.6. Ophthalmics royalty rates

Chapter 4 - Leading Ophthalmics deals and dealmakers

  • 4.1. Introduction
  • 4.2. Most active in Ophthalmics partnering
  • 4.3. List of most active dealmakers in Ophthalmics
  • 4.4. Top Ophthalmics deals by value

Chapter 5 - Ophthalmics contract document directory

  • 5.1. Introduction
  • 5.2. Ophthalmics partnering deals where contract document available

Chapter 6 - Ophthalmics dealmaking by therapeutic target

  • 6.1. Introduction
  • 6.2. Deals by Ophthalmics therapeutic target

Appendices

  • Appendix 1 - Directory of Ophthalmics deals by company A-Z 2010 to 2016
  • Appendix 2 - Directory of Ophthalmics deals by deal type 2010 to 2016
  • Appendix 3 - Directory of Ophthalmics deals by stage of development 2010 to 2016
  • Appendix 4 - Directory of Ophthalmics deals by technology type 2010 to 2016
  • Further reading on dealmaking
  • Deal type definitions
  • About Wildwood Ventures
  • Current Partnering
  • Current Agreements
  • Recent report titles from CurrentPartnering

Table of figures

  • Figure 1: Ophthalmics partnering since 2010
  • Figure 2: Ophthalmics partnering by deal type since 2010
  • Figure 3: Ophthalmics partnering by industry sector since 2010
  • Figure 4: Ophthalmics partnering by stage of development since 2010
  • Figure 5: Ophthalmics partnering by technology type since 2010
  • Figure 6: Ophthalmics partnering by indication since 2010
  • Figure 7: Ophthalmics deals with a headline value
  • Figure 8: Ophthalmics deals with upfront payment values
  • Figure 9: Ophthalmics deals with milestone payment
  • Figure 10: Ophthalmics deals with royalty rates
  • Figure 11: Active Ophthalmics dealmaking activity- 2010 to 2016
  • Figure 12: Top Ophthalmics deals by value since 2010
Back to Top